Evoke (LON:EVOK - Get Free Report)'s stock had its "buy" rating reissued by analysts at Berenberg Bank in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a GBX 95 ($1.28) price objective on the stock. Berenberg Bank's target price would indicate a potential upside of 49.61% from the company's current price.
Separately, JPMorgan Chase & Co. upped their price objective on Evoke from GBX 77 ($1.04) to GBX 80 ($1.08) and gave the stock a "neutral" rating in a research report on Thursday, July 10th.
Read Our Latest Report on EVOK
Evoke Stock Performance
Shares of LON:EVOK traded up GBX 1.20 ($0.02) on Wednesday, hitting GBX 63.50 ($0.86). 2,461,830 shares of the company's stock were exchanged, compared to its average volume of 2,077,188. The firm's 50-day moving average is GBX 62.88 and its 200 day moving average is GBX 60.32. The company has a market capitalization of £283.20 million, a PE ratio of -1.59 and a beta of 0.84. Evoke has a 1-year low of GBX 36.70 ($0.50) and a 1-year high of GBX 77.80 ($1.05).
Evoke (LON:EVOK - Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported GBX 1.20 ($0.02) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, analysts anticipate that Evoke will post 12.7648305 EPS for the current fiscal year.
Insider Activity
In related news, insider Per Widerström acquired 68,958 shares of Evoke stock in a transaction on Friday, May 23rd. The stock was purchased at an average cost of GBX 54 ($0.73) per share, with a total value of £37,237.32 ($50,273.15). Also, insider Sean Wilkins acquired 31,659 shares of Evoke stock in a transaction on Friday, May 23rd. The shares were bought at an average cost of GBX 54 ($0.73) per share, with a total value of £17,095.86 ($23,080.68). 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
(
Get Free Report)
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.